1-2 of 2
Gabrielle A Zecha, PA-C
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Throughput Drug Synergy Testing in a Clinical Trial of Panobinostat, Carfilzomib, Dexamethasone to Define Response Biomarkers for Relapsed/Refractory Multiple Myeloma

Pamela S. Becker, MD PhD, Kim Quach, Ted A Gooley, PhD, Edward N. Libby, III, MD, Andrew J. Cowan, MD, David G. Coffey, MD, Bret Gary Degraaff, BS, Cody Hammer, Jin Dai, PhD, Sylvia Chien, Josh Epworth, ARNP, Gabrielle A Zecha, PA-C, Heather Smith, PA-C, Timothy S Martins, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1902.
https://doi.org/10.1182/blood-2019-130990
Published: 2019
Journal Articles

Use of Gemtuzumab Ozogamicin for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML) or Acute Promyelocytic Leukemia (APL) in an Expanded Access Setting at Our Cancer Consortium

Kelda M Gardner, PA-C, Kathleen Shannon Dorcy, PhD RN, Rachele O'Leary, Donelle Rizzuto, RN, Roland B. Walter, MD PhD MS, Carole Shaw, Sunny So, RN, Paul C. Hendrie, MD PhD, Bart L Scott, MD, Mary Beth M. Percival, MD, Anna B. Halpern, MD, Ryan D. Cassaday, MD, Janis L. Abkowitz, MD, Bethany Murphy, Niall Curley, Cody Hammer, Heather Smith, PA-C, Gabrielle A Zecha, PA-C, Frederick R. Appelbaum, MD, Soheil Meshinchi, MD PhD, Colleen Delaney, MDMSc, Todd M Cooper, DO, Katherine Tarlock, MD, Elihu H. Estey, MD, Pamela S. Becker, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2710.
https://doi.org/10.1182/blood-2018-99-116908
Published: 2018